Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T15:37:06.742Z.
Calculation as of: 2026-10-06T15:37:06.742Z.
Quote observation: 2026-10-06T15:33:44.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 33649c4c01683a9af2a16592a0768676bab1dc5ff5bd6572e384150bc13b4d03
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$240.98M
Free Cash Flow Yield
16.67%
TTM Avg
15.02%
3Y Avg
15.02%
5Y Avg
15.02%
Market Cap
$242.35M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$240.97M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.62M
Free Cash Flow Yield
N/A
TTM Avg
1.67%
3Y Avg
1.64%
5Y Avg
2.28%
Market Cap
$237.69M
Free Cash Flow Yield
4.83%
TTM Avg
5.58%
3Y Avg
6.49%
5Y Avg
6.20%
Market Cap
$236.45M
Free Cash Flow Yield
N/A
TTM Avg
1.01%
3Y Avg
1.01%
5Y Avg
1.01%
Market Cap
$246.67M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InflaRx N.V. (IFRX) | $241.56M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.98M | 16.67% | 15.02% | 15.02% | 15.02% |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | N/A | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.97M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | N/A | 1.67% | 1.64% | 2.28% |
| High Tide Inc. (HITI)vs › | $237.69M | 4.83% | 5.58% | 6.49% | 6.20% |
| BioAge Labs Inc. (BIOA)vs › | $237.38M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $236.45M | N/A | 1.01% | 1.01% | 1.01% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $246.67M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $247.82M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
